SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

Povofortay Approved in Europe for Adults With Hidradenitis Suppurativa

Povofortay (povorcitinib) was approved in Europe as a once-daily oral treatment for adults with moderate to severe hidradenitis suppurativa.

INCY

Related stories